Lawrence Livermore National Laboratory’s (LLNL) technology transfer team has opened up multiple fronts to aid the nation’s efforts against the virus that causes COVID-19. IPO is investing in technology maturation and granting royalty-free, non-exclusive licenses for LLNL technologies that could be used against the pandemic.